Log in

NASDAQ:SILK - Silk Road Medical Stock Price, Forecast & News

$30.93
-2.36 (-7.09 %)
(As of 03/27/2020 04:00 PM ET)
Today's Range
$29.22
Now: $30.93
$33.28
50-Day Range
$23.16
MA: $39.09
$47.80
52-Week Range
$20.84
Now: $30.93
$51.50
Volume438,605 shs
Average Volume384,030 shs
Market Capitalization$969.66 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Silk Road Medical, Inc. operates as a medical device company in the United States. It offers ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent with clinical data regarding lasting safety outcomes; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was founded in 2007 and is headquartered in Sunnyvale, California.
Read More

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SILK
CUSIPN/A
CIKN/A
Phone408-720-9002

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$63.35 million
Book Value$2.33 per share

Profitability

Net Income$-52,420,000.00

Miscellaneous

Employees176
Market Cap$969.66 million
Next Earnings Date5/13/2020 (Estimated)
OptionableNot Optionable

Receive SILK News and Ratings via Email

Sign-up to receive the latest news and ratings for SILK and its competitors with MarketBeat's FREE daily newsletter.


Silk Road Medical (NASDAQ:SILK) Frequently Asked Questions

How has Silk Road Medical's stock been impacted by COVID-19 (Coronavirus)?

Silk Road Medical's stock was trading at $37.14 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, SILK stock has decreased by 16.7% and is now trading at $30.93. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Silk Road Medical?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Silk Road Medical.

When is Silk Road Medical's next earnings date?

Silk Road Medical is scheduled to release its next quarterly earnings announcement on Wednesday, May 13th 2020. View our earnings forecast for Silk Road Medical.

How were Silk Road Medical's earnings last quarter?

Silk Road Medical Inc (NASDAQ:SILK) announced its quarterly earnings data on Wednesday, February, 26th. The company reported ($0.27) EPS for the quarter, hitting the Thomson Reuters' consensus estimate of ($0.27). The firm had revenue of $18.63 million for the quarter, compared to analysts' expectations of $17.90 million. Silk Road Medical had a negative return on equity of 165.90% and a negative net margin of 82.73%. View Silk Road Medical's earnings history.

What guidance has Silk Road Medical issued on next quarter's earnings?

Silk Road Medical updated its FY 2020 After-Hours earnings guidance on Wednesday, February, 26th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $92-95 million, compared to the consensus revenue estimate of $94.02 million.

What price target have analysts set for SILK?

5 Wall Street analysts have issued 1 year target prices for Silk Road Medical's shares. Their forecasts range from $40.01 to $52.00. On average, they anticipate Silk Road Medical's share price to reach $46.20 in the next year. This suggests a possible upside of 49.4% from the stock's current price. View analysts' price targets for Silk Road Medical.

Has Silk Road Medical been receiving favorable news coverage?

News stories about SILK stock have trended extremely negative this week, InfoTrie Sentiment reports. The research firm rates the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Silk Road Medical earned a daily sentiment score of -5.0 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news aboutSilk Road Medical.

Are investors shorting Silk Road Medical?

Silk Road Medical saw a decrease in short interest during the month of February. As of February 14th, there was short interest totaling 1,140,000 shares, a decrease of 6.6% from the January 30th total of 1,220,000 shares. Based on an average daily trading volume, of 327,100 shares, the days-to-cover ratio is presently 3.5 days. Approximately 5.6% of the shares of the stock are sold short. View Silk Road Medical's Current Options Chain.

Who are some of Silk Road Medical's key competitors?

What other stocks do shareholders of Silk Road Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include Alibaba Group (BABA), Splunk (SPLK), Home Depot (HD), Honeywell International (HON), Cisco Systems (CSCO), DexCom (DXCM), salesforce.com (CRM), Thermo Fisher Scientific (TMO), Veeva Systems (VEEV) and Verizon Communications (VZ).

Who are Silk Road Medical's key executives?

Silk Road Medical's management team includes the following people:
  • Ms. Erica J. Rogers, Chief Exec. Officer, Pres & Director (Age 55)
  • Mr. Lucas W. Buchanan, Chief Financial Officer (Age 41)
  • Mr. Robert A. Nicholas, VP of Operations & Engineering (Age 56)
  • Mr. Andrew S. Davis, Exec. VP of Global Sales & Marketing (Age 50)
  • Ms. Alison Highlander, VP of HR

When did Silk Road Medical IPO?

(SILK) raised $75 million in an initial public offering on Thursday, April 4th 2019. The company issued 4,700,000 shares at $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch acted as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers.

What is Silk Road Medical's stock symbol?

Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK."

Who are Silk Road Medical's major shareholders?

Silk Road Medical's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Warburg Pincus LLC (19.13%), Janus Henderson Group PLC (6.25%), Alliancebernstein L.P. (4.73%), Bamco Inc. NY (4.41%), Jennison Associates LLC (3.97%) and Victory Capital Management Inc. (2.48%). Company insiders that own Silk Road Medical stock include Andrew S Davis, Erica J Rogers, Lucas W Buchanan, Pincus & Co Warburg, Richard Ruedy and X Finance LP Wp. View institutional ownership trends for Silk Road Medical.

Which institutional investors are selling Silk Road Medical stock?

SILK stock was sold by a variety of institutional investors in the last quarter, including Warburg Pincus LLC, Janus Henderson Group PLC, Lord Abbett & CO. LLC, Schonfeld Strategic Advisors LLC, Credit Suisse AG, Nicholas Investment Partners LP, ArrowMark Colorado Holdings LLC, and Advisor Group Inc.. Company insiders that have sold Silk Road Medical company stock in the last year include Andrew S Davis, Erica J Rogers, Lucas W Buchanan, Pincus & Co Warburg, Richard Ruedy, and X Finance LP Wp. View insider buying and selling activity for Silk Road Medical.

Which institutional investors are buying Silk Road Medical stock?

SILK stock was acquired by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, Alliancebernstein L.P., Cannell Peter B & Co. Inc., Parkman Healthcare Partners LLC, Jennison Associates LLC, Sectoral Asset Management Inc, Bamco Inc. NY, and Massachusetts Financial Services Co. MA. View insider buying and selling activity for Silk Road Medical.

How do I buy shares of Silk Road Medical?

Shares of SILK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Silk Road Medical's stock price today?

One share of SILK stock can currently be purchased for approximately $30.93.

How big of a company is Silk Road Medical?

Silk Road Medical has a market capitalization of $969.66 million and generates $63.35 million in revenue each year. The company earns $-52,420,000.00 in net income (profit) each year or ($1.36) on an earnings per share basis. Silk Road Medical employs 176 workers across the globe. View additional information about Silk Road Medical.

What is Silk Road Medical's official website?

The official website for Silk Road Medical is http://www.silkroadmed.com/.

How can I contact Silk Road Medical?

Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The company can be reached via phone at 408-720-9002 or via email at [email protected]


MarketBeat Community Rating for Silk Road Medical (NASDAQ SILK)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  55 (Thanks for Voting!)
Underperform Votes:  60 (Thanks for Voting!)
Total Votes:  115
MarketBeat's community ratings are surveys of what our community members think about Silk Road Medical and other stocks. Vote "Outperform" if you believe SILK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SILK will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel